| 000 | 01824 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513101403.0 | ||
| 264 | 0 | _c19961127 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0009-7330 | ||
| 024 | 7 |
_a10.1161/01.res.79.4.757 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoyama, H | |
| 245 | 0 | 0 |
_aThe fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. _h[electronic resource] |
| 260 |
_bCirculation research _cOct 1996 |
||
| 300 |
_a757-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aBecaplermin |
| 650 | 0 | 4 | _aCDC2-CDC28 Kinases |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase 2 |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinases _xmetabolism |
| 650 | 0 | 4 | _aCyclohexanes |
| 650 | 0 | 4 |
_aDNA Replication _xdrug effects |
| 650 | 0 | 4 | _aDrug Antagonism |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xpharmacology |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xmetabolism |
| 650 | 0 | 4 | _aO-(Chloroacetylcarbamoyl)fumagillol |
| 650 | 0 | 4 |
_aPlatelet-Derived Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-sis |
| 650 | 0 | 4 |
_aSesquiterpenes _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aNishizawa, Y | |
| 700 | 1 | _aHosoi, M | |
| 700 | 1 | _aFukumoto, S | |
| 700 | 1 | _aKogawa, K | |
| 700 | 1 | _aShioi, A | |
| 700 | 1 | _aMorii, H | |
| 773 | 0 |
_tCirculation research _gvol. 79 _gno. 4 _gp. 757-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.res.79.4.757 _zAvailable from publisher's website |
| 999 |
_c8825712 _d8825712 |
||